Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Disruption of androgen receptor signaling in males by environmental chemicals.

Luccio-Camelo DC, Prins GS.

J Steroid Biochem Mol Biol. 2011 Oct;127(1-2):74-82. doi: 10.1016/j.jsbmb.2011.04.004. Epub 2011 Apr 13. Review.

2.

Antiandrogens as environmental endocrine disruptors.

Kelce WR, Gray LE, Wilson EM.

Reprod Fertil Dev. 1998;10(1):105-11. Review.

PMID:
9727600
3.

Pathways of endocrine disruption during male sexual differentiation and masculinization.

Sharpe RM.

Best Pract Res Clin Endocrinol Metab. 2006 Mar;20(1):91-110. Review.

PMID:
16522522
5.

Environmental antiandrogens: developmental effects, molecular mechanisms, and clinical implications.

Kelce WR, Wilson EM.

J Mol Med (Berl). 1997 Mar;75(3):198-207. Review.

PMID:
9106076
7.

Endocrine disruptors: from endocrine to metabolic disruption.

Casals-Casas C, Desvergne B.

Annu Rev Physiol. 2011;73:135-62. doi: 10.1146/annurev-physiol-012110-142200. Review.

PMID:
21054169
8.

Combined exposures to anti-androgenic chemicals: steps towards cumulative risk assessment.

Kortenkamp A, Faust M.

Int J Androl. 2010 Apr;33(2):463-74. doi: 10.1111/j.1365-2605.2009.01047.x.

PMID:
20487045
9.

Environmental xenoestrogens, antiandrogens and disorders of male sexual differentiation.

Sultan C, Balaguer P, Terouanne B, Georget V, Paris F, Jeandel C, Lumbroso S, Nicolas J.

Mol Cell Endocrinol. 2001 Jun 10;178(1-2):99-105.

PMID:
11403899
10.

An updated review of environmental estrogen and androgen mimics and antagonists.

Sonnenschein C, Soto AM.

J Steroid Biochem Mol Biol. 1998 Apr;65(1-6):143-50. Review.

PMID:
9699867
11.

Gene-environment interactions in male reproductive health: special reference to the aryl hydrocarbon receptor signaling pathway.

Brokken LJ, Giwercman YL.

Asian J Androl. 2014 Jan-Feb;16(1):89-96. doi: 10.4103/1008-682X.122193. Review.

12.

Molecular mechanism(s) of endocrine-disrupting chemicals and their potent oestrogenicity in diverse cells and tissues that express oestrogen receptors.

Lee HR, Jeung EB, Cho MH, Kim TH, Leung PC, Choi KC.

J Cell Mol Med. 2013 Jan;17(1):1-11. doi: 10.1111/j.1582-4934.2012.01649.x. Epub 2012 Dec 20. Review.

13.

Mixtures of endocrine disrupting contaminants modelled on human high end exposures: an exploratory study in rats.

Christiansen S, Kortenkamp A, Axelstad M, Boberg J, Scholze M, Jacobsen PR, Faust M, Lichtensteiger W, Schlumpf M, Burdorf A, Hass U.

Int J Androl. 2012 Jun;35(3):303-16. doi: 10.1111/j.1365-2605.2011.01242.x. Epub 2012 Feb 28.

PMID:
22372636
14.

Endocrine disruptors and prostate cancer risk.

Prins GS.

Endocr Relat Cancer. 2008 Sep;15(3):649-56. doi: 10.1677/ERC-08-0043. Epub 2008 Jun 4. Review.

15.
16.

Interactions of methoxyacetic acid with androgen receptor.

Bagchi G, Hurst CH, Waxman DJ.

Toxicol Appl Pharmacol. 2009 Jul 15;238(2):101-10. doi: 10.1016/j.taap.2008.03.015. Epub 2008 Apr 7.

17.

Neuropeptides and enzymes are targets for the action of endocrine disrupting chemicals in the vertebrate brain.

Panzica GC, Bo E, Martini MA, Miceli D, Mura E, Viglietti-Panzica C, Gotti S.

J Toxicol Environ Health B Crit Rev. 2011;14(5-7):449-72. doi: 10.1080/10937404.2011.578562. Review.

18.

Mind the gap: can we explain declining male reproductive health with known antiandrogens?

Kortenkamp A, Scholze M, Ermler S.

Reproduction. 2014 Mar 2;147(4):515-27. doi: 10.1530/REP-13-0440. Print 2014.

19.

Similar causes of various reproductive disorders in early life.

Svechnikov K, Stukenborg JB, Savchuck I, Söder O.

Asian J Androl. 2014 Jan-Feb;16(1):50-9. doi: 10.4103/1008-682X.122199. Review.

20.

Developmental stage sensitivity and mode of action information for androgen agonists and antagonists.

Euling SY, Kimmel CA.

Sci Total Environ. 2001 Jul 2;274(1-3):103-13.

PMID:
11453286

Supplemental Content

Support Center